Chris Schott, Senior Analyst for U.S Major and Specialist Pharmaceuticals at J.P. Morgan Research, discusses the outlook for the sector, with a focus on the COVID-19 pandemic. Mr Schott notes that billions more doses of vaccine were available in 2022 compared with 2021, allowing a greater proportion of the global population to be vaccinated. He also notes how the innovation in other areas will impact the sector, including Alzheimer’s and diabetes.